VIENNA, Va.–(BUSINESS WIRE)– CEL-SCI Corporation (NYSE American: CVM) announces that it is
extending the expiration date of its Series DD and Series EE warrants to
March 1, 2018 (close of business). The Series DD and Series EE warrants
were issued as part of a financing on December 8, 2016. Following the
Company’s reverse split in June 2017, twenty-five (25) Series DD and
Series EE warrants will be required to purchase one share at an exercise
price of $4.50. All other terms of the warrants have remained the same.
About CEL-SCI Corporation
CEL-SCI’s work is focused on finding the best way to activate the immune
system to fight cancer and infectious diseases. The Company has
operations in Vienna, Virginia, and in/near Baltimore, Maryland.
Gavin de Windt, 703-506-9460
Source: CEL-SCI Corporation